Intragastric Balloon Market in LAMEA is expected to register a CAGR of 13.4% during the forecast period (2020-2026) - KBV Research

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report LAMEA Intragastric Balloon Market, published by KBV research, the LAMEA Intragastric Balloon Market would witness market growth of 13.4% CAGR during the forecast period (2020-2026).

The Brazil market dominated the LAMEA Triple Market by Country in 2019, and would continue to be a dominant market till 2026. The Argentina market would witness a CAGR of 14.7% during (2020 - 2026). Additionally, The UAE market is anticipated to witness a CAGR of 13.6% during (2020 - 2026).

The Saline Filled market dominated the Saudi Arabia Intragastric Balloon Market by Filling Material in 2019, thereby, achieving a market value of $529.3 Thousands by 2026. The Gas Filled market is experiencing highest CAGR of 14.6% during (2020 - 2026).

The Endoscopy market dominated the South Africa Intragastric Balloon Market by Administration in 2019, growing at a CAGR of 13.5 % during the forecast period. The Pill Form market is expected to witness a CAGR of 16.6% during (2020 - 2026).

Structural Insights: https://www.kbvresearch.com/lamea-intragastric-balloon-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Sientra, Inc. (Silimed, Inc.), Apollo Endosurgery, Inc., Obalon Therapeutics, Inc., ReShape Lifesciences Inc., Allurion Technologies, Inc., Helioscopie SA (Sante Actions Group), Districlass Medical SA, Spatz FGIA, Inc., Duomed Group (Life Partners Europe), Medsil.